Endocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Department of Pediatric Endocrinology, Marmara University School of Medicine, Istanbul, Turkey.
J Clin Endocrinol Metab. 2022 Mar 24;107(4):e1610-e1619. doi: 10.1210/clinem/dgab830.
Pseudohypoparathyroidism type Ib (PHP1B) is characterized by hypocalcemia and hyperphosphatemia due to parathyroid hormone resistance in the proximal renal tubules. Maternal pathogenic STX16/GNAS variants leading to maternal epigenetic GNAS changes impair expression of the stimulatory G protein alpha-subunit (Gsα) thereby causing autosomal dominant PHP1B. In contrast, genetic defects responsible for sporadic PHP1B (sporPHP1B) remain mostly unknown.
Determine whether PHP1B encountered after in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) causes GNAS remethylation defects similar to those in sporPHP1B.
Retrospective analysis.
Nine among 36 sporPHP1B patients investigated since 2000, all with loss of methylation (LOM) at the 3 maternal GNAS differentially methylated regions (DMRs) and gain of methylation at the paternal NESP DMR, had been conceived through IVF or ICSI. Besides abnormal GNAS methylation, IVF/ICSI PHP1B cases revealed no additional imprinting defects. Three of these PHP1B patients have dizygotic twins, and 4 have IVF/ICSI-conceived siblings, all with normal GNAS methylation; 2 unaffected younger siblings were conceived naturally.
Sporadic and IVF/ICSI-conceived PHP1B patients revealed indistinguishable epigenetic changes at all 4 GNAS DMRs, thus suggesting a similar underlying disease mechanism. Given that remethylation at the 3 maternal DMRs occurs during oogenesis, male factors are unlikely to cause LOM postfertilization. Instead, at least some of the sporPHP1B variants could be caused by a defect or defects in an oocyte-expressed gene that is required for fertility and for re-establishing maternal GNAS methylation imprints. It remains uncertain, however, whether the lack of GNAS remethylation alone and the resulting reduction in Gsα expression is sufficient to impair oocyte maturation.
假性甲状旁腺功能减退症 1b 型(PHP1B)的特征是由于近端肾小管对甲状旁腺激素抵抗导致低钙血症和高磷血症。导致母体遗传 GNAS 改变的母体致病性 STX16/GNAS 变异会损害刺激 G 蛋白 alpha 亚基(Gsα)的表达,从而导致常染色体显性 PHP1B。相比之下,导致散发性 PHP1B(sporPHP1B)的遗传缺陷仍大多未知。
确定体外受精(IVF)或胞浆内精子注射(ICSI)后遇到的 PHP1B 是否会引起类似于 sporPHP1B 的 GNAS 再甲基化缺陷。
回顾性分析。
自 2000 年以来,调查的 36 例 sporPHP1B 患者中有 9 例存在 3 个母体 GNAS 差异甲基化区域(DMR)的去甲基化(LOM)和父系 NESP DMR 的甲基化获得,这些患者均通过 IVF 或 ICSI 受孕。除了异常的 GNAS 甲基化外,IVF/ICSI PHP1B 病例没有发现其他印迹缺陷。这些 PHP1B 患者中有 3 例为异卵双胞胎,4 例为 IVF/ICSI 受孕的兄弟姐妹,所有患者的 GNAS 甲基化均正常;2 名未受影响的年轻兄弟姐妹均自然受孕。
散发性和 IVF/ICSI 受孕的 PHP1B 患者在所有 4 个 GNAS DMR 上均表现出相似的表观遗传变化,因此提示存在相似的潜在疾病机制。鉴于 3 个母体 DMR 的再甲基化发生在卵母细胞发生过程中,受精后男性因素不太可能导致 LOM。相反,至少一些 sporPHP1B 变异可能是由一个或多个卵母细胞表达的基因缺陷引起的,该基因对于生育能力和重新建立母体 GNAS 甲基化印记是必需的。然而,尚不确定缺乏 GNAS 再甲基化本身以及由此导致的 Gsα 表达减少是否足以损害卵母细胞成熟。